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1. Introduction
  Cholera, caused by Vibrio cholerae  (V. cholerae) O1 or O139, is 
one of the most severe forms of infectious diarrheas occurring 
globally. The etiological agent of the disease V. cholerae 
that belongs to serogroup O1 biotype El Tor has two major 
serotypes, Ogawa and Inaba. Both the serotypes V. cholerae 
O1 biotype El Tor Ogawa and V. cholerae O1 biotype El 
Tor Inaba, showing resistance to several antibiotics, have 
been reported to be involved in many cholera outbreaks 
in different parts of the globe[1-3], including India[4,5]. The 
incidence of cholera outbreaks is not uncommon in the 
West Bengal state, India, and Kolkata also faced several 
outbreaks due to the infection of V. cholerae Ogawa and 
V. cholerae Inaba with different resistance patterns to 
antibiotics[6,7]. Das et al reported cholera from North India 
due to V. cholerae O1 Ogawa showing resistance to nalidixic 
acid (Nx), furazolidone (Fz), cotrimoxazole (Co), tetracycline 
(T) and chloramphenicol (C)[8], which was in agreement with 
studies from Chandigarh and Kolkata, India[9]. Karki et al 
reported, from Nepal, the incidence of cholera caused by 
V. cholerae O1 Ogawa that were resistant to ampicillin (Am), 
Co, Nx and Fz[10]. The V. cholerae O1 Ogawa isolates from 
Mozambique showed resistance to Am, C, Co, T and Nx[11]. As 
has been reported by Chander et al, the all isolates obtained 
over a period of nine years (1999-2007) from Chandigarh, 
India, were V. cholerae O1 Ogawa, and the isolates showed 
changing pattern of antibiotic resistance[12]. 
  The multidrug resistances in V. cholerae have been 
reported to be plasmid encoded by earlier authors[13]; 
however, such phenomenon has been overlooked in our 
part of the globe. The emergence of multidrug resistant 
(MDR) V. cholerae, their changing antibiogram patterns 
and involvement of resistance-plasmid among the isolates 
are the cause of increased concern of treating cholera 
with antibiotics or reconsidering the role of antibiotics in 
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cholera outbreaks. The present study has, therefore, been 
undertaken to assess the antibiotic susceptibility pattern 
of V. cholerae O1 biotype El Tor serotype Ogawa isolates 
associated with a recent outbreak of cholera in Kolkata, 
India, and to explore the role of plasmid in mediating 
antibiotic resistance among them.
2. Materials and methods  
2. 1. Isolation and identification of bacteria
  The rectal swab samples (n=12) were collected in Cary-
Blair transport medium from patients in connection with 
an outbreak of watery diarrhea, occurred during middle 
of the June 2007, in Bally Municipality (Howrah district) 
Kolkata, India. The samples were inoculated, within 4-5 h of 
collection, into alkaline peptone water for enrichment, and 
then sub-cultured on thiosulphate citrate bile salt sucrose 
(TCBS) agar, McConkey agar and salmonella-shigella agar at 
the Department of Microbiology, Calcutta School of Tropical 
Medicine, India. Sucrose fermenting colonies on TCBS 
agar and non lactose fermenting colonies on the other two 
media were picked up, and tested biochemically following 
standard techniques[14]. Identity of V. cholerae isolates were 
further confirmed by serological tests using polyvalent O1 
and monovalent Ogawa and Inaba antisera obtained from 
Difco, USA. The isolated V. cholerae were biotyped by 
sheep red blood cell haemolysis, Voges-Proskauer test and 
susceptibility to Polymixin B (50 units)[14]. 
2.2. Antibiotic susceptibility test
  Antibiotic susceptibility testing for the isolated bacteria 
was done by disk diffusion technique as described earlier[15], 
on Mueller-Hinton agar (Hi-Media, Mumbai, India) using 
commercially available discs of antibiotics (Hi-Media, 
Mumbai, India): Am (10 毺g), C (30 毺g), trimethoprim 
(Tm, 5 毺g), T (30 毺g), erythromycin (Er, 15 毺g), Nx (30 
毺g), ciprofloxacin (Cp, 5 毺g), amikacin (Ak, 10 毺g) and 
cefotaxime (Cf, 30 毺g). Escherichia coli (E. coli) ATCC 
25922 was used as the control strain. The plates were read 
after 18 h incubation at 35 ℃. Zone diameter of inhibition 
(ZDI) for each antibiotic was interpreted as per the Clinical 
and Laboratory Standards Institute (previously National 
Committee for Clinical Laboratory Standards; NCCLS) 
guidelines[16].
2.3. Minimum inhibitory concentration determination
  The minimum inhibitory concentration (MIC) values of the 
antibiotics mentioned above for the isolated V. cholerae O1 
Ogawa were determined following the NCCLS guidelines[17]. 
The antibiotic concentrations used in this study ranged 0.5 - 
12 毺g/mL for C, Cp, Ak and Cf; 0.5 - 150 毺g/mL for Er and 
T; 2-75 毺g/mL for Nx; 0.5 - 250 and 50 - 250 毺g/mL for Am 
and Tm, respectively. E. coli ATCC 25922 was used as the 
control strain.
2. 4. Curing experiment 
  The isolated multidrug drug resistant (MDR) bacteria 
were subjected to plasmid curing at 40 ℃ to check the 
loss of resistance trait following the protocol of Anjanappa 
et al[18], with slight modification, and percent curing was 
calculated. The methodology in details has been mentioned 
elsewhere[15]. In this study the curing agent used was 
ethidium bromide (0.1 毺g/mL).
2.5. Plasmid DNA isolation and agarose gel electrophoresis
  The isolated MDR V. cholerae O1 Ogawa strains and 
their cured derivatives were subjected to plasmid DNA 
preparation following the protocols published earlier [19, 20], 
with some modification described elsewhere[15].
  The isolated plasmid DNAs were electrophoresed through 
0.8% agarose gel (Sigma, USA) for 4 h in tris-borate buffer 
system in horizontal gel apparatus. The gel was stained 
with ethidium bromide (Sigma, USA) solution (0.5 毺g/mL 
of double distilled water) for 30 min, and documented with 
Gel-Doc system. The plasmid DNA of E. coli V517 (53.7 kb) 
was employed as a molecular size marker. Plasmid sizes 
were estimated from the migration distance in the agarose 
gel relative to the migration distance of reference E. coli 
V517 plasmid, by the method of Rochelle et al[21]. Repeated 
extraction of plasmid DNA was carried out for all isolates.
3. Results
  The all clinical bacterial isolates studied showed typical 
biochemical and serological reactions of V. cholerae and 
were identified as V. cholerae O1 biotype El Tor serotype 
Ogawa. Thus, a total of 12 V. cholerae O1 Ogawa were 
isolated, one from each of the 12 rectal swab samples, which 
were collected (from 12 patients involved in the cholera 
outbreak) and processed microbiologically.  
  The all 12 (100%) V. cholerae O1 Ogawa isolates were 
sensitive to C, Ak and Cf having ZDI 19-24 mm, 20-26 mm 
and 22-27 mm, respectively, and resistant to Tm with no 
ZDI for 6 (50.00%) isolates (6 mm), and ZDI as 8-9 mm for 
the remaining 6 (50.00%) isolates. Of 12 isolates, 11 (91.66%) 
showed resistance to T and Er having no ZDI (6 mm) to 12 
mm, and to 10 mm ZDI, respectively, while the sensitive one 
had ZDI as 20 mm and 26 mm, respectively. The Am ZDIs of 
8-10 mm for 7 (58.33%) and 19-23 mm for 5 (41.67%) isolates, 
respectively, indicate their resistance and susceptibility 
to the antibiotic. To the quinolone antibiotics, Nx and Cp, 
respectively 7 (58.33%) and 5 (41.67%) resistant isolates 
had ZDI≤10 mm and ≤11 mm, respectively; the sensitive 
isolates had Nx ZDI 19-24 mm and Cp ZDI 20-23 mm. 
  All the isolated V. cholerae O1 Ogawa (12, 100.00%) showed 
susceptibility to C and Cf having MICs 2-8 毺g/mL, and 
Ak (MICs 2-4 毺g/mL), and resistance to Tm (MICs 75-200 
毺g/mL). Most of the isolates (11, 91.66%) were resistant 
to T (MICs 75-100 毺g/mL) and Er (MICs 64-128 毺g/mL), 
while the sensitive one had Er MIC of 2 毺g/mL and T MIC 
of 4 毺g/mL. Among the isolates, 7 (58.33%) were resistant 
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to Am and Nx with MICs 75-200 毺g/mL and 32-64 毺g/
mL, respectively, and the sensitive isolates (n=5, 41.67%) 
had MICs 2-4 毺g/mL and 4-8 毺g/mL, respectively. For 
7 (58.33%) and 5 (41.67%) of the isolates, the Cp MICs were 
0.66 毺g/mL (sensitive isolates) and 10 毺g/mL (resistant 
isolates), respectively. 
  Based upon the MICs and disc diffusion test results, the 
V. cholerae O1 Ogawa isolates shared multiple antibiotic 
resistance showing three different patterns: AmTmTErNx 
(for 6 isolates), TmTErCp (for 5 isolates), and AmTmNx for 
one isolate. Following ethidium bromide treatment the 
MDR isolates having resistance patterns: AmTmTErNx, 
TmTErCp and AmTmNx, respectively lost AmTmTEr-, TmTEr- 
and AmTm-resistances with 79%, 83% and 72% curing, 
respectively; the isolates retained Nx and Cp resistances.
  It showed the plasmid DNA bands, in the gel, isolated from 
V. cholerae O1 Ogawa having different antibiotic resistance 
patterns, as well as the 53.7 kb molecular marker plasmid 
from E. coli V517 strain. The plasmid DNA isolated from V. 
cholerae O1 Ogawa strain having AmTmTErNx-resistance 
showed single plasmid band co-migrated with the 53.7 
kb plasmid from E. coli V517 strain, while the V. cholerae 
O1 Ogawa strains having resistance patterns TmTErCp and 
AmTmNx showed single plasmid bands, co-migrated with 
each other, of approximately 50 kb. The cured derivatives of 
the isolated V. cholerae O1 Ogawa strains losing AmTmTEr-, 
TmTEr- and AmTm- resistances did not show any plasmid 
band in the gel (Figure 1).         
53.7 kb
1              2             3             4             5             6           7            8
Figure 1.  Agarose gel electrophoresis of plasmid DNAs extracted 
from V. cholerae O1 Ogawa strains. 
Lane 1: plasmid size marker of 53.7 kb from E. coli V517, Lane 2 & 
3: V. cholerae O1 Ogawa S2 strain (resistance pattern AmTmTErNx), 
Lane 4 & 5: V. cholerae O1 Ogawa S19 strain (resistance psttern 
TmTErCp), Lane 6 & 7: V. cholerae O1 Ogawa S11 strain (resistance 
pattern AmTmNx), Lane 8: Cured derivative of V. cholerae O1 Ogawa 
S2 strain (Nx resistant). Plasmid DNAs of Lane 2, 4 and 6 were 
isolated by Kado and Liu method [ref: 27], and for others Birnboim 
and Doly [ref: 28] method was followed.
4. Discussion
  The all V. cholerae isolates obtained from the cases 
involved in an out break of watery diarrhea in Kolkata, 
India in 2007 were confirmed as V. cholerae O1 biotype El 
Tor serotype Ogawa. The V. cholerae O1 Ogawa associated 
cholera outbreak has been reported earlier from Kolkata[22], 
wherein during the last decade, the dominance of V. cholerae 
O1 Ogawa was observed. Outbreaks causing V. cholerae 
O1 Ogawa isolates have been reported from Chandigarh, 
India[4,12]. V. cholerae O1 Ogawa were isolated from 24 out 
of 48 stool samples obtained from patients in an explosive 
cholera outbreak in Gujrat, India, giving a positivity rate 
of 50%[23]. The V. cholerae O1 El Tor isolates from Mumbai, 
India were of Ogawa serotype during 2007[24] and 2004-
2005[25]. All El Tor V. cholerae isolates from patients involved 
in an outbreak of cholera in the Sangli, Maharashtra were 
of Ogawa serotype[26]. During cholera outbreaks (2000-2006) 
in Iran, V. cholerae O1 Ogawa were isolated, as has been 
reported by Tavana et al[3]. Thus, the V. cholerae O1 biotype 
El Tor serotype Ogawa has been reported from different 
parts of the world including India, and has firmly been 
established in Kolkata, West Bengal state, the homeland 
of the disease. However, incidence of the V. cholerae O1 
biotype El Tor serotype Inaba has been described in many 
parts of India[5,27,28], and the V. cholerae O1 strains have 
been demonstrated to interconvert and to undergo serotype 
switching between Ogawa and Inaba. In Kolkata, India, 
V. cholerae O1 Ogawa serotype predominated the Inaba 
serotype during 2004; the reverse was true for 2005[6]. During 
2004 and 2005, two diarrheal outbreaks caused by V. cholerae 
O1 serotypes Ogawa and Inaba in two differrrrent areas of 
the West Bengal state, India, have been reported[7]. The 
present communication reports a focal outbreak of cholera in 
Kolkata, India, where the all 12 (100%) V. cholerae O1 were 
of Ogawa serotype; no other serotypes were traced. Regular 
surveillance of cholera endemic regions for V. cholerae 
infection may prevent occurrence of such outbreaks in the 
future.
  Excessive and imprudent antibiotic use is generally 
considered to be the principal driving force behind the 
growing prevalence of antibiotic resistance among bacterial 
pathogens, and the previous use of antibiotics in earlier 
outbreaks may be in part responsible, as well, for the 
extensive increase in antibiotic resistance. The earlier 
authors from different parts of the world including India 
reported various patterns of resistance among the V. cholerae 
O1 strains to antibiotics generally used in the treatment of 
cholera. The V. cholerae O1 Ogawa and Inaba isolates from 
Iran showed resistance to Co, Nx and Fz,  intermediately 
susceptible to C, and susceptible to T, Cp and Er[1]. High 
incidences of antimicrobial resistance among V. cholerae 
O1 isolates from Mozambique were found for C (57.9%), Co 
(96.6%) and T (97.3%), while quinolone resistance remained 
low (4.2%)[11]. Jesudasan[29] reported from Vellore, India 
T-resistance among the Inaba serotype, and T-sensitivity 
among the Ogawa strains; the isolates showing resistance 
to Nx and Co has also been reported earlier from the same 
place among both Ogawa and Inaba strains, and TmNx-
resistance and sensitivity to T, C, Cf and Cp have been 
reported too[28]. Pal et al reported that among the V. cholerae 
O1 isolates from different outbreak regions of Orissa, India, 
both Ogawa and Inaba strains uniformly showed sensitivity 
to Am, C, gentamycin (G), norfloxacin (Nf), Cp, and T, while 
Fz, neomycin (Nm) and Nx resistances were found only among 
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Ogawa strains[5]. Sharma et al reported from Delhi, India 
that in V. cholerae O1 Inaba, multidrug resistance was 98.6% 
and in V. cholerae O1 Ogawa 98.3%; the isolates showed 100% 
resistances to Fz and Nx, and 100% sensitivity to T[30]. The all 
V. cholerae O1 isolates involved in the two outbreaks during 
2004 - 2005 in West Bengal state, India were sensitive to T, 
G, azithromycin (Az) and Cp (but with reduced susceptibility 
to Cp for the V. cholerae isolated from the Garulia outbreak), 
and resistant to Am, Co, Nx and Fz[7]. The V. cholerae O1 
Ogawa and Inaba strains from Kolkata (2004-2005) showed 
multidrug resistance to Am (76.0-100.0% isolates), Co (67.5-
100.0% isolates), Fz (100.0% isolates), Nx (90.9-100.0% 
isolates), and Str (97.3-100.0% isolates); the resistance to Cf 
and T were 5.3-36.7% and 27.3%, respectively for Ogawa, 
and 12.5% and 15.0%, respectively for Inaba isolates[6]. 
In the present study, the outbreak causing V. cholerae O1 
biotype El Tor serotype Ogawa isolates also showed various 
resistance patterns, viz., AmTmTErNx, TmTErCp and AmTmNx. 
The different pattern of antibiotic resistance was due to 
both temporal and spatial differences in the antibiotic 
treatment regimens, and thus continuous surveillance of 
cholera outbreaks is necessary with particular reference to 
resistance pattern of the isolates.
  In the present communication, we determined MICs of the 
antibiotics used in the study, and the susceptibility test 
results from the disk diffusion method corroborated the 
results from the MICs of the antibiotics for the V. cholerae 
O1 Ogawa isolates. Most of the earlier authors did not report 
antibiotic MICs, for the test isolates, which is one of the 
essential criteria in determining susceptibility in order to 
make antibiotic treatment policy. All the V. cholerae Ogawa 
isolates, which were moderately sensitive to T by disc 
diffusion method had an MIC for T of 8 毺g/mL, while the T 
sensitive strains had MICs in between 4 mg/mL and 1 毺g/
mL[26]. Jesudasan[29] showed T-sensitivity among V. cholerae 
O1 Ogawa and Inaba strains by MIC that ranged 8-16 毺g/
mL. The V. cholerae Inaba isolates from North India showed 
high MICs of Nx (>128 毺g/mL) and Tm (64 毺g/mL), while 
the low MICs for the isolates indicated sensitivity to Cf and T 
(0.25-2 毺g/mL), Cp (0.25-0.5 毺g/mL), Ak and G (0.25-4 毺
g/mL), and moderate sensitivity to C and amoxicillin (Ax) (16 
毺g/mL)[28]. Das et al recoded increasing trend of Cp MICs 
(2-128 毺g/mL) among V. cholerae O1 Ogawa and Inaba 
strains from east Delhi, India during 2004-2006[31]. The 
high range of MICs among the current V. cholerae O1 Ogawa 
isolates, extending from very low level for some antibiotics 
to very high level for others, is probably due to judicious use 
of some antibiotics or withdrawal of some indiscriminately 
used antibiotics from the treatment protocol against enteric 
bacterial infection, for certain period of time, or rampant 
application of some extensively used antibiotics in the 
treatment of all enteropathogenic including V. cholerae 
infections, as we have seen earlier related to Salmonella 
enterica serovar Typhi and S. enterica serovar Paratyphi A 
infection[32,33].
  The overall evolution of antibiotic resistance can be 
attributed to the spread of R-plasmid to various bacterial 
pathogens mainly because of the selective forces imposed 
by humans due to the overuse of antibiotics. But, inspire 
of a marked increase of MDR cholera outbreaks in different 
parts of India including Kolkata, no report has appeared of 
any outbreak due to MDR V. cholerae carrying R-plasmids. 
However, plasmid encoded drug resistance are not 
uncommon among the current sporadic as well as outbreak 
causing V. cholerae strains in the globe. Plasmid mediated 
resistance to Am, C, Str, sulfamethoxazole (Smz) and Tr has 
been reported among V. cholerae O1 isolates from Ethiopia, 
Somalia and Kenya[13]. The presence of a plasmid of about 
150 kb in V. cholerae O1 isolates showing resistance to Am, 
C, T, Tm, Str, kanamycin and extended spectrum betalactams 
has been reported by Petroni et al[34]. To the best of our 
knowledge this is the first report of isolation of plasmid 
DNAs (approximately 53.7 kb encoding AmTmTEr-resistance, 
and approximately 50 kb conferring TmTEr- and AmTm-
resistances) among V. cholerae O1 biotype El Tor serotype 
Ogawa isolates involved in a cholera out break in Kolkata, 
India during 2007. Thus, the present study highlights the 
necessity for vigilance of R-plasmid among the V. cholerae 
strains currently emerged in and around Kolkata, India and 
other parts of the world in order to combat plasmid mediated 
multidrug-resistance. 
  The cholera outbreaks that occur seasonally, in dry 
(March-April) to rainy (September-October) seasons, are 
a regular feature in Kolkata, and the West Bengal state is 
known as the homeland of V. cholerae. In this study, although 
the number of isolates is low, 100% isolation of V. cholerae 
was made, and the isolates were resistant to multiple 
antibiotics with different patterns of resistances, which 
were plasmid mediated too. Hence, such type of outbreak 
should not be ignored; rather, continuous monitoring of the 
changing trends in antimicrobial resistance patterns and 
vigilance of R-plasmid is a must, because the emergence 
of such resistance amongst V. cholerae may significantly 
influence the control strategies in future outbreaks. Over all, 
the long-term control of cholera depends on good personal 
hygiene, an uncontaminated water supply and appropriate 
sewage disposal.
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